The American College of Cardiology (ACC) has a new leader at a pivotal moment for cardiovascular health. Dr. Roxana Mehran assumed the presidency of the nearly 60,000-member organization today, March 30, 2026, stepping into a role demanding both scientific rigor and a keen understanding of evolving healthcare challenges. This isn’t simply a changing of the guard; it signals a potential shift in priorities for the ACC as it navigates an increasingly complex landscape of chronic disease, preventative care, and health equity.
- Leadership Transition: Dr. Mehran is the new president of the ACC, beginning a one-year term.
- Focus on Global Partnerships: A key priority will be strengthening the ACC’s international collaborations.
- Emphasis on Vulnerable Populations: Dr. Mehran has explicitly stated a commitment to improving care for the most vulnerable patients.
Dr. Mehran’s appointment comes as cardiovascular disease remains the leading cause of death globally, and as healthcare systems worldwide grapple with the long-term effects of the COVID-19 pandemic – which exacerbated existing cardiovascular risks and revealed disparities in access to care. Her background as a renowned interventional cardiologist, researcher, and advocate for women in medicine positions her uniquely to address these challenges. Notably, her leadership of the Women’s Heart and Vascular Center at Mount Sinai reflects a growing, and critically important, focus on sex-specific differences in cardiovascular health – an area historically underrepresented in research and clinical practice.
The ACC’s role has expanded beyond traditional clinical guidelines and education. It now actively engages in data collection through registries like NCDR (National Cardiovascular Data Registry), influencing policy, and promoting patient engagement through initiatives like CardioSmart. Dr. Mehran’s extensive history of service within the ACC, including contributions to guideline development, suggests a deep understanding of the organization’s internal workings and a commitment to its existing framework. However, her track record of founding organizations like Women as One also hints at a willingness to champion innovative approaches.
The Forward Look
Dr. Mehran’s presidency is likely to accelerate several key trends within the ACC and the broader cardiovascular field. Expect increased emphasis on:
- Digital Health Integration: The ACC has already begun exploring the use of telehealth, remote monitoring, and AI-driven diagnostics. Dr. Mehran’s leadership will likely push for wider adoption and integration of these technologies, particularly to address access barriers in underserved communities.
- Value-Based Care Models: The shift towards rewarding quality of care over volume is gaining momentum. The ACC will likely play a more active role in defining metrics and promoting best practices for value-based cardiovascular care.
- Global Health Equity: Dr. Mehran’s stated focus on global partnerships suggests a greater emphasis on addressing cardiovascular health disparities internationally. This could involve collaborations with organizations in low- and middle-income countries to improve access to essential medications and technologies.
- Continued Focus on Women’s Cardiovascular Health: Given her established expertise, expect increased research funding and educational initiatives focused on understanding and addressing the unique cardiovascular needs of women.
The ACC’s Annual Scientific Session in New Orleans, where Dr. Mehran officially assumes the presidency, will be a key event to watch for early signals of her priorities and strategic direction. The selection of other new officers – including Vice President Hani Najm and Board of Trustees members – also provides clues about the ACC’s evolving leadership landscape. The next year promises to be a dynamic period for the organization, and for the field of cardiovascular medicine as a whole.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
